Outset Medical, Inc.OMEarnings & Financial Report
Nasdaq
OM Q4 2025 Key Financial Metrics
Revenue
$28.9M
Gross Profit
$12.2M
Operating Profit
$-17.6M
Net Profit
$-19.5M
Gross Margin
42.4%
Operating Margin
-61.1%
Net Margin
-67.5%
YoY Growth
-2.0%
EPS
$0.33
Financial Flow
Outset Medical, Inc. Q4 2025 Financial Summary
Outset Medical, Inc. reported revenue of $28.9M for Q4 2025, with a net profit of $-19.5M (-67.5% margin). Cost of goods sold was $16.6M, operating expenses totaled $29.9M.
Key Financial Metrics
| Total Revenue | $28.9M |
|---|---|
| Net Profit | $-19.5M |
| Gross Margin | 42.4% |
| Operating Margin | -61.1% |
| Report Period | Q4 2025 |
Outset Medical, Inc. Annual Revenue by Year
Outset Medical, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $119.5M).
| Year | Annual Revenue |
|---|---|
| 2025 | $119.5M |
| 2024 | $113.7M |
| 2023 | $130.4M |
| 2022 | $115.4M |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.2M | $27.4M | $28.7M | $29.5M | $29.8M | $31.4M | $29.4M | $28.9M |
| YoY Growth | -15.8% | -24.0% | -5.6% | -3.4% | 5.6% | 14.7% | 2.7% | -2.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $346.2M | $314.5M | $292.9M | $275.8M | $301.2M | $288.8M | $277.3M | $264.5M |
| Liabilities | $253.0M | $245.9M | $245.1M | $249.0M | $131.3M | $134.0M | $134.9M | $137.5M |
| Equity | $93.2M | $68.6M | $47.8M | $26.8M | $169.9M | $154.8M | $142.4M | $127.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-45.9M | $-33.3M | $-20.6M | $-16.5M | $-25.7M | $-4.8M | $-6.3M | $-9.5M |